logo
Book a meeting
Glycologix

Glycologix

Biotechnology, 100 Cummings CTR, BEVERLY, Massachusetts, 01915, United States, 1-10 Employees

glycologix.com

  • LinkedIn

phone no Phone Number: +19*********

Who is GLYCOLOGIX

Glycologix Inc. is an emerging biotechnology company targeting locally delivered biopolymers for the protection of soft tissues. Multiple unmet medical conditions can be addressed by repl...

Read More

lock icon Get Full Access
map
  • 100 Cummings CTR, BEVERLY, Massachusetts, 01915, United States Headquarters: 100 Cummings CTR, BEVERLY, Massachusetts, 01915, United States
  • 2016 Date Founded: 2016
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: Under $1 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 8731

checked-icon Does something look wrong? Fix it. | View contact records from GLYCOLOGIX

Glycologix Org Chart and Mapping

Employees
Richard Heidebrecht

Richard Heidebrecht

Vice President of Research and Development

See Full Org Chart arrow
email-formate-icon
View Email Formats for Glycologix
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding Glycologix

Answer: Glycologix's headquarters are located at 100 Cummings CTR, BEVERLY, Massachusetts, 01915, United States

Answer: Glycologix's phone number is +19*********

Answer: Glycologix's official website is https://glycologix.com

Answer: Glycologix's revenue is Under $1 Million

Answer: Glycologix's SIC: 8731

Answer: Glycologix has 1-10 employees

Answer: Glycologix is in Biotechnology

Answer: Glycologix contact info: Phone number: +19********* Website: https://glycologix.com

Answer: Glycologix Inc. is an emerging biotechnology company targeting locally delivered biopolymers for the protection of soft tissues. Multiple unmet medical conditions can be addressed by replenishment of naturally occurring proteoglycans. Our platform discovery engine enables the preparation of synthetic structural mimics of proteoglycans. Despite their high molecular weight, these novel materials are are highly soluble, enabling optimal tissue coverage. Focused indications for the platform include interstitial cystitis, dry eye, post-surgical adhesion prevention, osteoarthritis, spinal disk disease, and wound repair. Glycologix is supported in part by grants from the NIH.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access